This document discusses how APIs are enabling new ways of accessing and mashing up drug discovery data from various sources. It provides examples of existing bio/chem/med APIs and case studies of companies that are using APIs in novel ways for tasks like patent chemistry searching and therapeutic intelligence analysis. The document advocates for making APIs more accessible to allow broader exploration of data that can uncover new use cases and insights, while also noting challenges around usability, data discovery, and security.